On April 8, 2021 Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary genetic engineering platform technologies to create cell and gene therapeutics with the capacity to cure, reported that the Company will participate in the following upcoming virtual investor conferences (Press release, Poseida Therapeutics, APR 8, 2021, View Source [SID1234577745]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Raymond James Cell Therapy for Oncology Symposium
Start-up to Scale-up: A Discussion on Manufacturing of Off The Shelf Cell Based Therapy
Panel discussion with Poseida CEO Eric Ostertag, MD, PhD
Thursday, April 22, 2021
9:00am ET

7th Annual Truist Securities 2021 Life Sciences Summit
Fireside Chat with Poseida CEO Eric Ostertag, MD, PhD
Wednesday, May 5, 2021
3:30pm ET

Webcasts will be available on the Investors & Media Section of the Poseida website, www.poseida.com. An archived replay of each webcast will be available for approximately 30 days following each presentation.